Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, exerts its anti-cancer effect by binding to and inhibiting exportin 1 (XPO1), which is the main nuclear export protein for hundreds of cargoes including tumor suppressor proteins (TSPs) and growth regulatory proteins [6]. This evidence concerns the gene XPO1 and cancer.